BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24350692)

  • 1. A comparison of NAL and DSL prescriptive methods for paediatric hearing-aid fitting: predicted speech intelligibility and loudness.
    Ching TY; Johnson EE; Hou S; Dillon H; Zhang V; Burns L; van Buynder P; Wong A; Flynn C
    Int J Audiol; 2013 Dec; 52 Suppl 2(0 2):S29-38. PubMed ID: 24350692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing NAL-NL1 and DSL v5 in Hearing Aids Fit to Children with Severe or Profound Hearing Loss: Goodness of Fit-to-Targets, Impacts on Predicted Loudness and Speech Intelligibility.
    Ching TY; Quar TK; Johnson EE; Newall P; Sharma M
    J Am Acad Audiol; 2015 Mar; 26(3):260-74. PubMed ID: 25751694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of gain for adults from generic hearing aid prescriptive methods: impacts on predicted loudness, frequency bandwidth, and speech intelligibility.
    Johnson EE; Dillon H
    J Am Acad Audiol; 2011; 22(7):441-59. PubMed ID: 21993050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An initial-fit comparison of two generic hearing aid prescriptive methods (NAL-NL2 and CAM2) to individuals having mild to moderately severe high-frequency hearing loss.
    Johnson EE
    J Am Acad Audiol; 2013 Feb; 24(2):138-50. PubMed ID: 23357807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Different Hearing Aid Prescriptions for Children.
    Marriage JE; Vickers DA; Baer T; Glasberg BR; Moore BCJ
    Ear Hear; 2018; 39(1):20-31. PubMed ID: 28691934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern prescription theory and application: realistic expectations for speech recognition with hearing AIDS.
    Johnson EE
    Trends Amplif; 2013; 17(3):143-70. PubMed ID: 24253361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional outcomes for speech-in-noise intelligibility of NAL-NL2 and DSL v.5 prescriptive fitting rules in hearing aid users.
    Portelli D; Loteta S; Ciodaro F; Salvago P; Galletti C; Freni L; Alberti G
    Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3227-3235. PubMed ID: 38546852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing loudness normalization (IHAFF) with speech intelligibility maximization (NAL-NL1) when implemented in a two-channel device.
    Keidser G; Grant F
    Ear Hear; 2001 Dec; 22(6):501-15. PubMed ID: 11770672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-over, double-blind comparison of the NAL-NL1 and the DSL v4.1 prescriptions for children with mild to moderately severe hearing loss.
    Ching TY; Scollie SD; Dillon H; Seewald R
    Int J Audiol; 2010 Jan; 49 Suppl 1():S4-15. PubMed ID: 20109088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of the NAL-NL2 and DSL v5.0a prescription procedures in the adaptation of hearing aids in the elderly.
    Bertozzo MC; Blasca WQ
    Codas; 2019 Aug; 31(4):e20180171. PubMed ID: 31433039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fitting hearing aids to individual loudness-perception measures.
    Ricketts TA
    Ear Hear; 1996 Apr; 17(2):124-32. PubMed ID: 8698159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of real-world preferences and performance of hearing aids fitted according to the NAL-NL1 and DSL v5 procedures in children with moderately severe to profound hearing loss.
    Quar TK; Ching TY; Newall P; Sharma M
    Int J Audiol; 2013 May; 52(5):322-32. PubMed ID: 23570290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing aid fitting and developmental outcomes of children fit according to either the NAL or DSL prescription: fit-to-target, audibility, speech and language abilities.
    Ching TYC; Zhang VW; Johnson EE; Van Buynder P; Hou S; Burns L; Button L; Flynn C; McGhie K
    Int J Audiol; 2018 May; 57(sup2):S41-S54. PubMed ID: 28971727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children's speech perception and loudness ratings when fitted with hearing aids using the DSL v.4.1 and the NAL-NL1 prescriptions.
    Scollie SD; Ching TY; Seewald RC; Dillon H; Britton L; Steinberg J; King K
    Int J Audiol; 2010 Jan; 49 Suppl 1():S26-34. PubMed ID: 20109085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hearing-aid safety: a comparison of estimated threshold shifts for gains recommended by NAL-NL2 and DSL m[i/o] prescriptions for children.
    Ching TY; Johnson EE; Seeto M; Macrae JH
    Int J Audiol; 2013 Dec; 52 Suppl 2(0 2):S39-45. PubMed ID: 24350693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Modified Hearing Aid Fittings on Loudness and Tone Quality for Different Acoustic Scenes.
    Moore BC; Baer T; Ives DT; Marriage J; Salorio-Corbetto M
    Ear Hear; 2016; 37(4):483-91. PubMed ID: 26928003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAL-NL2 empirical adjustments.
    Keidser G; Dillon H; Carter L; O'Brien A
    Trends Amplif; 2012 Dec; 16(4):211-23. PubMed ID: 23203416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fitting recommendations and clinical benefit associated with use of the NAL-NL2 hearing-aid prescription in Nucleus cochlear implant recipients.
    English R; Plant K; Maciejczyk M; Cowan R
    Int J Audiol; 2016; 55 Suppl 2():S45-50. PubMed ID: 26853233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAL-NL1 procedure for fitting nonlinear hearing aids: characteristics and comparisons with other procedures.
    Byrne D; Dillon H; Ching T; Katsch R; Keidser G
    J Am Acad Audiol; 2001 Jan; 12(1):37-51. PubMed ID: 11214977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is normal or less than normal overall loudness preferred by first-time hearing aid users?
    Smeds K
    Ear Hear; 2004 Apr; 25(2):159-72. PubMed ID: 15064661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.